Gene · 9588
Papers2,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications. | Elife | 2023 | 37995198 | PubTator, text mining | PubMed |
| [Research Progress of Nrf2 and Ferroptosis in Tumor Drug Resistance]. | Zhongguo Fei Ai Za Zhi | 2023 | 37989339 | PubTator, text mining | PubMed |
| Identification ferroptosis-related hub genes and diagnostic model in Alzheimer's disease. | Front Mol Neurosci | 2023 | 37965040 | PubTator, text mining | PubMed |
| Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. | Biomark Res | 2023 | 37941057 | PubTator, text mining | PubMed |
| Alteration of chromatin high-order conformation associated with oxaliplatin resistance acquisition in colorectal cancer cells. | Exploration (Beijing) | 2023 | 37933235 | PubTator, text mining | PubMed |
| Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma. | Nat Commun | 2023 | 37932266 | PubTator, text mining | PubMed |
| NOX1 and PRDX6 synergistically support migration and invasiveness of hepatocellular carcinoma cells through enhanced NADPH oxidase activity. | Adv Redox Res | 2023 | 37900981 | PubTator, text mining | PubMed |
| NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells. | Acta Neuropathol Commun | 2023 | 37875948 | PubTator, text mining | PubMed |
| Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers. | Clin Proteomics | 2023 | 37875819 | PubTator, text mining | PubMed |
| Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome. | Orphanet J Rare Dis | 2023 | 37872602 | PubTator, text mining | PubMed |
| Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular Carcinoma. | Front Cell Dev Biol | 2023 | 37842089 | PubTator, text mining | PubMed |
| The mechanism of ferroptosis and its related diseases. | Mol Biomed | 2023 | 37840106 | PubTator, text mining | PubMed |
| Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors. | Cancers (Basel) | 2023 | 37835514 | PubTator, text mining | PubMed |
| Robust AMBER Force Field Parameters for Glutathionylated Cysteines. | Int J Mol Sci | 2023 | 37834470 | PubTator, text mining | PubMed |
Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography-Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression. | Int J Mol Sci | 2023 | 37834160 | PubTator, text mining | PubMed |
| Calcein-Modified CeO2 for Intracellular ROS Detection: Mechanisms of Action and Cytotoxicity Analysis In Vitro. | Cells | 2023 | 37830630 | PubTator, text mining | PubMed |
| Synergistic roles of CBX4 chromo and SIM domains in regulating senescence of primary human osteoarthritic chondrocytes. | Arthritis Res Ther | 2023 | 37828576 | PubTator, text mining | PubMed |
| Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine. | J Transl Med | 2023 | 37814261 | PubTator, text mining | PubMed |
| Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. | Front Oncol | 2023 | 37810967 | PubTator, text mining | PubMed |
| Phospholipases A and Lysophospholipases in protozoan parasites. | Microb Cell | 2023 | 37786811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9588/papers?page=12